Skip to content

Healing, Harms, and Humility: Expanding the Scope of Psychedelic-Assisted Psychotherapy Research.

Kelley C. O’donnell, Jim Grigsby, Charles S. Grob

Am J Psychiatry January 1, 2025 DOI: 10.1176/appi.ajp.20230785 via PubMed

Summary

AI-generated from the abstract

A comprehensive review argues that psychedelic-assisted psychotherapy research should expand beyond clinical efficacy to include potential harms, diverse patient experiences, and ethical integration. The authors advocate for a balanced approach that examines both therapeutic benefits and risks, emphasizing humility in interpreting findings. They call for broader investigation into how context, patient diversity, and responsible integration shape outcomes, rather than focusing solely on symptom reduction. The review highlights the need to address challenges such as adverse effects, cultural appropriation, and equitable access to ensure the full impact of these treatments is understood.

Study at a glance

Characteristics Review Peer reviewed
Topics Psychedelic-assisted therapy
Keywords Promising treatments Therapeutic power Research scope
Citations 9
Key finding Psychedelic-assisted psychotherapy research must expand its scope to include harms, diverse patient experiences, and ethical integration for a balanced understanding of its therapeutic power.

Abstract

Healing, Harms, and Humility: Expanding the Scope of Psychedelic-Assisted Psychotherapy Research.

Explore topics

Comments

No comments yet.

Log in to comment